The aim of the study was to evaluate the occurrence of atheromatous plaques in carotid, aortic and femoral arteries, focusing on blood pressure (BP). The study subjects consisted of 65-year-old Finns drawn from a population-based cohort. Ultrasonographic measurements were performed on 54 diabetic subjects, 97 subjects with impaired glucose tolerance (IGT) and 57 normoglycaemic subjects (NGT). High systolic BP (SBP) was defined as X160 mmHg and high diastolic BP as X95 mmHg. High pulse pressure (PP) was defined as the highest tertile (X75 mmHg) of PP and high mean BP (MBP) as the highest tertile (X111 mmHg) of MBP. The prevalence of atheromatous plaques was 77% (160/208) in carotid arteries, 94% (195/208) in aorta and 77% (161/ 208) in femoral arteries. A total of 64% (134/208) of the subjects had plaques in both carotid and femoral arteries, and they were compared with those who had plaques in 0-1 of these arteries. In addition to male gender and long-lasting smoking, the occurrence of plaques in both carotid and femoral arteries were associated with high SBP and high MBP. According to the results of multiple regression analyses, the adjusted odds ratio for plaques in both carotid and femoral arteries was 3.1 (95% CI 1.5-6.5) in subjects with high SBP compared to those with lower SBP. When SBP was replaced by high MBP, the adjusted odds ratio for it was 2.3 (95% CI 1.1-4.8).
Introduction
Hypertension plays an important role in the development of atherosclerosis. 1 Systolic blood pressure (SBP) and pulse pressure (PP) increase with age. 2 Several studies have shown that high SBP is a risk factor for carotid intima-media thickening. [3] [4] [5] [6] [7] [8] Elevated PP has also been associated with carotid intima-media thickening. 3, 6, 8 Intima-media thickening has been suggested to represent an early phase of atherosclerosis preceding the development of plaques. 9 Only some studies have evaluated the association of hypertension 5, [10] [11] [12] [13] [14] with the occurrence of atherosclerotic plaques, and the mechanism linking hypertension with plaques remains poorly understood. In a recent study, carotid echogenic plaques were associated with increased aortic arterial stiffness measured by carotid-femoral pulse wave velocity. 15 After the age of 50 years, increased arterial stiffness is associated with elevated SBP and PP. 16 Therefore, analysis of the different components of BP (SBP, diastolic (DBP), pulse (PP) and mean blood pressure (MBP)) together with the occurrence of atherosclerotic plaques would clarify the association between hypertension and atherosclerotic plaques.
We carried out a population-based study on the determinants of ultrasonographic manifestations of atherosclerosis in northern Finland. Recently, we reported the results on the intima-media thickening of carotid arteries. [17] [18] [19] Low insulin sensitivity measured by QUICKI, high (X170 mmHg) SBP, long-lasting smoking and male gender were independently associated with severe intima-media thickening. In the present paper, we evaluate the occurrence of atheromatous plaques in the carotid arteries, aorta and femoral arteries, focusing on BP. Our purpose was to find out if the risk factors for atheromatous plaques and intima-media thickening were different.
Materials and methods
The study subjects consisted of 65-year-old Finns drawn from a population-based cohort. 20 In 1998, altogether 60 subjects of the cohort had clinical diabetes, defined as either diabetes diagnosed by a physician before the baseline or as two elevated blood glucose values (either fasting blood glucose values of X6.1 mmol/l or 2-h OGTT values of X11.1 mmol/l) during this study in 1992-1998. All subjects with clinical diabetes (except one with cancer) and those with impaired glucose tolerance (IGT) on the basis of the 1996-1998 OGTT results were invited to participate in the present study. In addition, for each diabetic subject, a control subject with normoglycaemic test results in OGTTs in 1992 and 1996-1998 was invited to participate. The diabetic and normoglycaemic groups were matched for gender, current smoking and BMI class.
This population-based study was started in northern Finland in 1990, to assess the prevalence of diabetes mellitus (DM) and IGT. 20 All of the 1008 subjects born in 1935 and living in Oulu, a city of 100 000 inhabitants, on 1 October 1990, were invited to participate in the study. Altogether 768 subjects attended the OGTTs, and the participation rate was 78%. In 1994 and 1996-1998, two follow-up studies were carried out. 17, 21, 22 OGTTs were performed at these follow-up visits.
Questionnaires, interviews, clinical examinations and laboratory tests were used to collect data during the follow-up study in 1996-1998. Self-reported use of antihypertensive medication was recorded in the questionnaire, and 44% (91/208) of the present study subjects used some antihypertensive medication. b-blockers were the most common drugs. The use of diuretics, calcium channel blockers and ACE inhibitors were less frequent than that of b-blockers. Two measurements of BP were made by the radiologist from the right arm in a recumbent position, when the subject had rested for about half an hour after the ultrasound examination. The mean value of these two measurements was used in the analyses. Hypertension was defined as either a SBP of 160 mmHg or more or a DBP of 95 mmHg or more or being on antihypertensive medication regardless of the BP values. 23 MBP was calculated as 2/3 DBP þ 1/3 SBP. It was divided into tertiles, and subjects in the highest tertile (X111 mgHg) were compared with those in the lower tertiles. PP was also divided into tertiles, and subjects in the highest tertile (X75 mmHg) were compared with those in the lower tertiles.
A standardized 75-g OGTT was performed according to the instructions of the WHO Study Group. 24 After a fast of 10-12 h, a venous blood sample was drawn at 0800-1000 hours to obtain a fasting glucose value and values for fasting immunoreactive insulin, total cholesterol, high-density lipoprotein (HDL) cholesterol and triglycerides. After that, a 75-g glucose load was given to the participants. At 2 h, a capillary sample was collected for the 2-h glucose value. The concentration of blood glucose was determined with the hexokinase-glucose-6-phosphate dehydrogenase method (Merck Diagnostica, Darmstadt, Germany). The coefficients of variation (CV) for within-run studies were between 1.7 and 2.8%, depending on the glucose concentration. For day-to-day studies, the CV was 2.8% at the upper end of the reference range.
Serum immunoreactive insulin concentration was measured by radioimmunoassay using the Phadeseph Insulin RIA100 kit (Pharmacia Diagnostics AB, Uppsala, Sweden), which also detects proinsulin and proinsulin conversion products with considerable sensitivity. The crossreactivity of proinsulin in this assay is about 41%. Insulin levels were not analysed from the samples of the diabetic patients with insulin treatment.
To measure insulin sensitivity, a novel quantitative insulin-sensitivity check index (QUICKI) was used. 25, 26 QUICKI can be determined from fasting insulin and glucose values according to the equation: QUICKI ¼ 1/[log(I 0 ) þ log(G 0 )], where I 0 is fasting insulin and G 0 is fasting glucose.
Ultrasound examinations
The ultrasound examinations were carried out between 15 February and 29 September 2000 at the Department of Diagnostic Radiology, Oulu University Hospital. They were conducted using a colour Doppler ultrasound system (Toshiba PowerVision 7000 or 8000) with a scanning frequency of 9 MHz in B-mode, following the same protocol throughout, by a single trained radiologist (MP) blinded to the participants' glucose status. Each carotid system was imaged in anterior oblique and lateral planes, transversally and longitudinally, with the subject supine and the head turned away from the examiner at an angle of 451. Each scan of a common carotid artery began just above the clavicle and was continued cephalically through the bifurcation and along both the internal and external branches as far distally as possible. Common femoral arteries were scanned in the inguinal ligament region. The scanned artery length was about twice the transducer's width (about 8 cm), and the scanning frequency was 9 MHz in carotid and common femoral arteries. Abdominal aorta was scanned from the renal artery level to the bifurcation with a convex 4.4 MHz transducer. The examiner consistently aimed at the clearest possible image of the near and far walls of the arteries. The scan head was kept perpendicular to the arterial wall to give optimal visualization. Doppler scanning was used to identify the vessels and to evaluate flow disturbances.
Representative images of plaques were recorded, and the whole scanning procedure was recorded on a Super-VHS video cassette recorder (Panasonic, Osaka, Japan). All measurements were made about 6 months later from the video image on the monitor of the ultrasound device, using its electronic calipers.
The dimensions measured were the intima-media thickness (IMT), the number of atheromatous plaques and the maximal diameter of a plaque. Arterial plaque was defined as an echogenic structure encroaching into the vessel lumen with a distinct area and resulting in more than 50% greater IMI compared to the neighbouring sites. 27 The total number of plaques in the arteries on both sides were used in the analysis of carotid and femoral arteries presented in this paper. In all, 54 (92%) of the subjects with clinical diabetes, 97 (95%) of those with IGT and 57 (97%) of the normoglycaemic subjects (NGT) underwent ultrasound measurements.
Statistical methods
The differences between the group means of the continuous variables were tested for significance by Student's t-test, ANOVA, Mann-Whitney U-test and Kruskall-Wallis test as appropriate. The dichotomized variables were compared with the w 2 test. Since the numbers of plaques were non-normally distributed, Spearman's correlation coefficients were used. The subjects with plaques in both carotid and femoral arteries were compared with the subjects who had plaques in one or none of these arteries. After bivariate analyses, multiple regression analyses with the occurrence of plaques in both carotid and femoral arteries as a dependent variable were performed. The variables that had been associated significantly with the occurrence of plaques at both sites were fitted into the model, and log-likelihood statistics was used in model building. The possible interaction of BP with glucose status was tested by interaction terms. P-values lower than or equal to 0.05 were considered statistically significant. All the statistical analyses were made with the SPSS for Windows software, version 10.0.
Results
The characteristics of the study population in relation to glucose status are shown in Table 1 . SBP, DBP, PP, MBP and the use of antihypertensive drugs increased with the deterioration of glucose status. Diabetic subjects had lower QUICKI than the other groups.
A large proportion of the study population had atheromatous plaques: the prevalence of plaques was 77% (160/208) in carotid arteries, 94% (195/ 208) in aorta and 77% (161/208) in femoral arteries. There was a strong positive correlation between the number plaques in different arteries: the correlation coefficient for carotid/femoral arteries was 0.492 (Po0.001), that for carotid artery/aorta 0.310 (Po0.001) and that for femoral artery/aorta 0.313 (Po0.001). Men had a higher number of plaques than women in carotid and femoral arteries ( Table 2) .
The median number of carotid plaques were 2 (range 0-11) in diabetic subjects, 2 (range 0-9) in subjects with IGT and 1 (range 0-7) in NGT (P ¼ 0.145). In aorta, the corresponding numbers were 3 (range 0-10), 3 (range 0-13) and 2 (range 0-13), respectively (P ¼ 0.578). The median number (and range) of femoral plaques were 4 (0-22), Data represent n, mean7s.d., or percentage, except for fasting triglycerides, which are represented as median (range).
Blood pressure and atherosclerotic plaques U Rajala et al 3 (0-33) and 3 (0-32) in subjects with DM, IGT and NGT, respectively (P ¼ 0.792). The numbers of carotid, aortic and femoral plaques did not differ statistically significantly between the groups defined according to QUICKI tertiles. The number of plaques in subjects stratified by hypertension status is presented in Table 3 . The number of femoral plaques was and that of carotid plaques tended to be higher in hypertensive than in normotensive subjects. The numbers of plaques stratified according to BP without taking into account the possible use of antihypertensive medication are presented in Table 4 . The number of plaques in carotid arteries was and that of femoral plaques tended to be higher in subjects with high (X160 mmHg) SBP than in those with low (o160 mmHg) SBP. Instead, there was no statistically significant difference in the number of aortic plaques between the groups. When the subjects were stratified according to DBP or PP, there were no statistically significant differences in the number of plaques in carotid, aortic or femoral arteries. The number of carotid plaques was and that of femoral arteries tended to be higher in subjects with high MBP (X111 mmHg) than in those with lower MBP.
In carotid arteries, the maximal diameter of plaque was greater in the subjects with high (X160 mmHg) SBP than in those with low (o160 mmHg) SBP: 2.0 mm (range 0-5.4) and 1.6 mm (range 0-5.0), respectively (P ¼ 0.012). The corresponding values in aorta were 3.3 mm (range 0-8.9) and 3.3 mm (range 0-12.5) (P ¼ 0.832). In femoral arteries the values were 3.1 mm (range 0-6.3) and 2.8 mm (range 0-7.1), respectively (P ¼ 0.237). When the subjects were stratified according to DBP (X95 mmHg vs o95 mmHg), there were no statistically significant differences in the maximal diameter of carotid, aortic or femoral plaques.
Of the subjects, 64% (134/208) had plaques in both carotid and femoral arteries; 26% (53/208) had plaques in either a carotid or femoral artery, and only 10% (21/208) did not have plaques in either carotid or femoral arteries. The characteristics of the subjects with plaques in both carotid and femoral arteries compared to those with plaques in 0-1 of these arteries are presented in Table 5 . In addition to male gender, the occurrence of plaques in both carotid and femoral arteries was associated with long-lasting smoking, high (X160 mmHg) SBP and high (X111 mmHg) MBP. High (X95 mmHg) DBP and high (X75 mmHg) PP also tended to be associated with the occurrence of plaques in both arteries. HDL cholesterol tended to be lower and LDL cholesterol higher in the former than the latter group. The interaction terms for SBP with glucose status (P ¼ 0.366) and BP with glucose status (P ¼ 0.315) were not statistically significant. Therefore, multiple regression analyses were performed in the whole study population. The results of multiple regression analyses are shown in Table 6 . Two models are presented. Male gender, long-lasting smoking and high (X160 mmHg) SBP were independently associated with plaques in both carotid and femoral arteries. The adjusted odds ratio (OR) of the subjects with high SBP was 3.1 (95% CI 1.5-6.5). The OR for male gender was 2.2 (95% CI 1.1-4.3) and that for long-lasting smoking 7.8 (95% CI 2.1-28.7). When SBP was replaced by high (X111 mmHg) MBP, the adjusted OR for it was 2.3 (95% CI 1.1-4.8) (model 2). Blood pressure and atherosclerotic plaques U Rajala et al
Discussion
The prevalence of plaques in carotid, aortic and femoral arteries was high in the present study population. There was a close relationship between hypertension, especially high SBP, and plaques in carotid and femoral arteries. Of the subjects, 64% had plaques in both carotid and femoral arteries. The subjects with high (X160 mmHg) SBP had a three-fold risk for plaques in both carotid and femoral arteries compared to those with lower SBP. In addition, male gender and long-lasting smoking were risk factors for the occurrence of carotid and femoral plaques. In the present study population, aortic plaques were not associated with hypertension. The risk factors for atheromatous plaques and intima-media thickening were the same, with the exception of low insulin sensitivity, which proved to be a risk factor only for the latter. The prevalence of carotid, aortic and femoral plaques increases with age, 10, [13] [14] [28] [29] [30] and the rather high age (65 years) of the subjects partly explains the high occurrence of plaques in the present study population. Nevertheless, the prevalence of carotid plaques was higher in this study (77%) than in a population-based study of British subjects with a mean age of 66 years (57% in men and 58% in women).
14 Some earlier studies have shown an association between diabetes and carotid plaques. 28, 31 In the present study, the occurrence of carotid plaques tended to be higher in diabetic subjects and subjects with IGT than in subjects with NGT. The present study subjects were selected from a population-based cohort by inviting all subjects with clinical diabetes and IGT and, in addition, by selecting a normoglycaemic control subject for each diabetic subject. Of the study subjects, 73% had clinical diabetes or IGT. The selection of subjects may have contributed to the high prevalence of carotid plaques in the present study.
The present study showed a close relationship between plaques and hypertension, especially high SBP and carotid and femoral plaques. This is in accordance with the previous results concerning carotid arteries. 5, 12, 14 We did not find any previous studies evaluating only the possible association between SBP and plaques in either femoral arteries or aorta. Simon et al 13 studied the risk factors for plaques in carotid, aortic and femoral arteries and showed that the SBP of the study subjects increased with an increasing number of arteries with plaques.
BP consists of a steady component, represented by MBP, and a pulsatile component, that is, PP. 16 In middle-aged hypertensive subjects, increased vascular resistance elevates MBP. With ageing, SBP rises progressively. 32 DBP peaks earlier and declines after the age of 55 years in men and after 60 years in women. As a consequence, pulse pressure increases with age. The age-related rise of PP (and SBP) is associated with increased arterial stiffness and alterations in wave reflections. 16 Arterial stiffness can be measured by pulse wave velocity (PWV), and the results of a recent study showed that subjects with echogenic carotid plaques had increased PWV compared to subjects without plaques. 15 Instead, echolucent plaques were not associated with increased PWV. The limitation of our study was that we assessed only echogenic plaques. In addition, we did not measure arterial stiffness.
SBP was rather high in the present study population, 18 however, we do not know if the high SBP was due to arterial stiffness or alterations in wave reflections. Nevertheless, most of the study subjects had type II diabetes or IGT, and previous studies have suggested that such subjects may have stiffer Blood pressure and atherosclerotic plaques U Rajala et al vessels than subjects with abnormal glucose tolerance. 33 Except for high SBP, high MBP was also associated with plaques in this study population. Apart from BP, male gender 5, 12, 28, 30 and smoking [13] [14] 30 are well-established risk factors for atheromatous plaques.
Carotid atherosclerosis measured by ultrasound appears to be associated with coronary artery disease 34 and to predict myocardial infarction. 35 In a recent large study, carotid and femoral atherosclerosis detected by ultrasound identified a group of subjects at high risk for cardiovascular events and deaths during the following 10 years. 36 In their study, Belcaro et al 36 used a new classification of carotid and femoral arterial wall changes detected by ultrasound. The atherosclerotic changes were divided into four classes, and the researchers were able to identify a risk group consisting of 20% of the study population, in which 98.6% of the cardiovascular events and deaths occurred. The subjects with atheromatous plaques were divided into classes where the risk for events ranged from 39 to 81%. In the present study, the classification of Belcaro et al 36 was not used. Nevertheless, we suggest that the subjects with atheromatous plaques in both carotid and femoral arteries consisted of a risk group for cardiovascular events.
We have previously reported results on intimamedia thickening of carotid arteries. [17] [18] [19] Severe intima-media thickening (maximal IMT of the common carotid artery X1.2 mm) was independently associated with low insulin sensitivity measured by QUICKI. Subjects in the two lowest QUICKI tertiles had a five-fold risk for severe intima-media thickening compared to those with the highest QUICKI tertile. 17 In addition, maximal IMT increased from the lowest to the highest quartile of SBP, and the subjects within the highest quartile of SBP (X170 mmHg) had a threefold risk for severe intima-media thickening compared to those with lower SBP. 18 In addition, severe intimamedia thickening was associated with male gender and long-lasting smoking. 17, 18 The risk factors for severe carotid intima-media thickening and plaques in carotid and femoral arteries were mainly the same in the present study population. The only exception was low insulin sensitivity, which proved to be a risk factor for severe carotid intima-media thickening, but did not seem to associate significantly with plaques. Because intima-media thickening has been suggested to represent an earlier phase of atherosclerosis than plaques, it is possible that low insulin sensitivity is associated with an early phase of atherosclerosis.
In conclusion, the prevalence of plaques was high in carotid, aortic and femoral arteries in the present study population. There was a close association between carotid and femoral plaques and hypertension, especially high SBP and MBP. The subjects with high (X160 mmHg) SBP had a three-fold and the subjects in the highest tertile of MBP a two-fold risk for plaques in both carotid and femoral arteries compared to those with lower BP. Of the study subjects, 73% had DM or IGT, and we suggest that the results can be generalized to apply to elderly subjects with DM and IGT, but not to NGT.
